Diagnostic test for ovarian cancer

Thursday, 01 January, 2009 | Supplied by: Manalto Inc

The OvPlex Panel is an early detection test for ovarian cancer, developed by HealthLinx in collaboration with ARL Pathology.

The test works by measuring five different biomarkers (proteins) in blood that are associated with ovarian cancer. It then builds a diagnostic based on that information rather than relying on a single marker for the disease.

Results are available within a fortnight.

Online: www.healthlinx.com.au
Phone: 03 9208 4200

Hygiena foodproof Salmonella plus Cronobacter Detection LyoKit

Hygiena's foodproof Salmonella plus Cronobacter Detection LyoKit is an ISO...

Dojindo Laboratories ExoIsolator Exosome Isolation Kit

The ExoIsolator Exosome Isolation Kit, from Dojindo Laboratories, can collect exosomes...

Beckman Coulter Life Sciences Basophil Activation Test (BAT) for food allergy research

Beckman Coulter Life Sciences introduces its next-generation Basophil Activation Test (BAT) to...

Content from other channels on our network

Injectable tech for fresh produce could extend shelf life

Manufacturing most impacted by ransomware in Q1 2025

Balancing packaging waste and food waste through data-driven design

Call for comment on thermolysin as a processing aid

No kidding: Australia's goatmeat exports at all-time high

Digital displays in health care: benefits for patients and staff

Doctors' warning — Bupa's plans risk a US-style health model

NSWNMA: Proposed workers comp changes a "cruel blow"

Nursing and Midwifery Board waives renewal late fee until 15 June

Victoria's 2025–26 State Budget claims frontline care record

CeMAT 2025 incorporates processing, packaging and more

WA Government investing $500 million to unlock industrial areas

Homegrown solar pioneer first to be funded for Solar Sunshot

Researchers show robots how to identify an object's properties through handling

UAE-funded consortium to build a waste‍-‍to‍-‍energy facility in Parkes